| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 7.92 CAD | 0.09 (+1.15%) | 5.91 - 7.92 | -- |
Market data as of 12:00AM 05/17/13. Quotes are delayed by at least 15 min.
The investment objective of the fund is to track the performance of the Morgan Stanley Capital International Europe Index (MSCI Europe Index). The MSCI Europe Index is a diversified index of about 600 widely held companies in the developed countries in Europe.
| Total Return | 0.25% |
|---|---|
| Yield (Trailing 12 Mo.) | 2.25% |
| Expense Ratio | -- |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | -- |
| Management Tenure | 7 Years |
| Fund Inception | 04/30/1998 |
| Timeframe | MUTUAL:TDB659 | S&P 500 | European Equity |
|---|---|---|---|
| 1 Month | -1.61% | 1.93% | 2.36% |
| 3 Month | 3.81% | 7.18% | 2.80% |
| Year-to-Date | 3.81% | 12.74% | 7.69% |
| 1 Year | 11.61% | 16.89% | 19.66% |
| 3 Year | 4.07% | 12.80% | 7.25% |
| 5 Year | -2.95% | 5.21% | -1.80% |
| 10 Year | 4.96% | 7.88% | 4.81% |
| Since Inception | 0.25% | 10.38% | -- |
| Basic Materials | 9.20% | |
|---|---|---|
| Consumer Cyclical | 8.94% | |
| Financial Services | 19.27% | |
| Real Estate | 1.03% | |
| Consumer Defensive | 14.53% | |
| Healthcare | 12.13% | |
| Utilities | 3.99% | |
| Communication Services | 5.34% | |
| Energy | 10.65% | |
| Industrials | 12.09% | |
| Technology | 2.84% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 0.00 | 0.00 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.09 | 0.10 | 0.02 | ||
| Foreign Stock | 0.00 | 99.70 | 99.70 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.09 | 99.80 | 99.72 | ||
| Cash | 0.00 | 0.28 | 0.28 | ||
| Total Net Assets | $48.64M |
|---|---|
| Total Stock Holdings | 433 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Nestle SA | 11.35% | 2.90% |
| HSBC Holdings PLC | 0.48% | 2.71% |
| Novartis AG | 12.97% | 2.01% |
| Roche Holding AG | 16.70% | 1.96% |
| BP PLC | 1.44% | 1.83% |
| Royal Dutch Shell PLC Class A | -5.52% | 1.78% |
| Vodafone Group PLC | 12.90% | 1.71% |
| Sanofi | -- | 1.56% |
| Total SA | -- | 1.53% |
| GlaxoSmithKline PLC | 5.86% | 1.50% |
| Valuation | MUTUAL:TDB659 | Category Range |
|---|---|---|
| Price/Earnings | 11.46 | |
| Price/Book | 1.42 | |
| Price/Sales | 0.83 | |
| Price/Cash Flow | 7.34 | |
| Dividend Yield | 3.35 | |
| LT Earnings | 7.94 | |
| Historical Earnings | 8.21 | |
| Sales Growth | -4.45 | |
| Cash-Flow Growth | -12.9 | |
| Book-Value Growth | 1.11 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Above Avg | |
| Return | Below Avg |
| Pretax Return | 4.07% |
|---|---|
| Tax-adjusted Return | 2.75% |
| Tax Cost Ratio | 1.27% |
| Potential Cap Gains | -- |
